Recruiting Clinical Trials

Displaying 51 - 60 of 227 result(s)
Study Title Condition Phase Location
A Non-interventional Study Evaluating Injectable Treatments (Ofatumumab, Glatiramer Acetate and Interferon β1) in Patients With Relapsing Multiple Sclerosis [AIOLOS] Relapsing Multiple Sclerosis Not Given
  • Country: 
    Germany
A Twelve-Month, Randomized, Double-Masked, Multicenter, Phase III, Two-Arm Study Comparing the Efficacy and Safety of Brolucizumab 6 mg Versus Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration Neovascular Age-Related Macular Degeneration Phase 3
  • Country: 
    China
A Prospective Multicenter Study for the Assessment of Treatment Patterns, Effectiveness and Safety of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis in a Real-world Setting in China Psoriasis Not Given
  • Country: 
    China
An Open-label, Non-randomized Extension Study to Evaluate the Long-term Efficacy, Safety and Tolerability of LNP023 in Subjects With C3 Glomerulopathy C3 Glomerulopathy Phase 2
  • Country: 
    France
  • Country: 
    United Kingdom
Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent (Siponimod): An OTIS Observational Pregnancy Surveillance Study Multiple Sclerosis Not Given
  • Country: 
    United States
A Phase I/II, Multi-center, Open Label Study of DYP688 in Patients With Metastatic Uveal Melanoma (MUM) and Other GNAQ/11 Mutant Melanomas Metastatic Uveal Melanoma Phase 1, Phase 2
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    France
  • Country: 
A Phase Ib/II Open Label Dose Confirmation, Proof of Concept Study of Siremadlin in Combination With Venetoclax Plus Azacitidine in Unfit Adult AML Participants Who Responded Sub-optimally to First-line Venetoclax Plus Azacitidine Treatment and in Pa ... Acute Myeloid Leukemia Phase 1, Phase 2
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Hong Kong
  • Country: 
Phase IIIb, Open-label, Single-arm, Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of OAV101 Administered Intrathecally (1.2 x 10^14 Vector Genomes) to Participants 2 to 12 Years of Age With Spinal Muscular Atrophy (SMA) Who Hav ... Spinal Muscular Atrophy Phase 3
  • Country: 
    Canada
  • Country: 
    Netherlands
A Phase Ib/II Open-label, Multi-center Dose Escalation Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small-Cell Lung, Carcinoma, Colorectal, Cancer of Lung, Cancer of the Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary, Pulmonary Cancer, Pulmonary Neoplasms Phase 1, Phase 2
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Belgium
  • Country: 
A Phase 1, Open-label, Multi-center, Single-dose, Parallel Group Study to Evaluate the Pharmacokinetics of Siremadlin (HDM201) in Participants With Mild, Moderate and Severe Hepatic Impairment Compared to Matched Healthy Control Participants Hepatic Impairment Phase 1
  • Country: 
    United States